Point6 Bio
PrivateLast Round
Seed
May 1, 2023
Total Funding Raised
$1.4M
Company Overview
Point6 Bio is a biotechnology company that develops an AI-driven computational biology platform for the early diagnosis and treatment of neurodevelopmental and neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Point6 Bio Comparables
Compare Point6 Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iDiagnostix Ltd | 84% | |
| Andia Health | 83% | |
| Cell-El Therapeutics Ltd. | 83% | |
Point6 Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 1, 2023 | ||||
| Grant | Mar 21, 2023 |
Point6 Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| VLX Ventures | Seed |
| Endless Frontier Labs | Seed |
Point6 Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Point6 Bio's valuation, stock price, and market status.